Henrik Rasmussen Email

Chairman the Board Directors Renibus . Rénibus Therapeutics

Current Roles

Employees:
38
Revenue:
$3.8M
About
Rénibus Therapeutics is a clinical-stage biotech company dedicated to transforming the cardiorenal disease treatment paradigm by focusing on the prevention and treatment of kidney disease. The company’s portfolio includes RBT-1 for prevention of acute kidney injury, RBT-2 for treatment of chronic kidney disease, and RBT-3 for treatment of iron deficiency anemia and platinum-based kidney toxicity.
Rénibus Therapeutics Address
181 Grand Ave
Southlake, TX
Rénibus Therapeutics Email

Past Companies

Rénibus Therapeutics IncChairman of the Board of Directors of Renibus
Dren Bio, Inc.Consultant Medical Advisor
Saghmos TherapeuticsConsultant Medical Advisor and independent Director of the BOD

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.